These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22003284)

  • 1. Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia.
    Mauriño J; Sanjúan J; Haro JM; Díez T; Ballesteros J
    Patient Prefer Adherence; 2011; 5():471-4. PubMed ID: 22003284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophrenia.
    Mauriño J; Cordero L; Ballesteros J
    Patient Prefer Adherence; 2012; 6():83-5. PubMed ID: 22298947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective Well-Being Under Neuroleptics Scale short form (SWN-K): reliability and validity in an Estonian speaking sample.
    Haring L; Mõttus R; Jaanson P; Pilli R; Mägi K; Maron E
    Ann Gen Psychiatry; 2013 Sep; 12(1):28. PubMed ID: 24025191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective well-being, but not subjective mental functioning shows positive associations with neuropsychological performance in schizophrenia-spectrum disorders.
    Schroeder K; Huber CG; Jelinek L; Moritz S
    Compr Psychiatry; 2013 Oct; 54(7):824-30. PubMed ID: 23602393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Spanish version of the Subjective Well-being under Neuroleptic Scale (SWN-K) in patients with schizophrenia].
    Sanjúan J; Haro JM; Mauriño J; Díez T; Ballesteros J
    Med Clin (Barc); 2012 Feb; 138(4):151-4. PubMed ID: 21571347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
    Schennach-Wolff R; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Jäger M; Möller HJ; Riedel M
    Eur Psychiatry; 2011; 26(5):284-92. PubMed ID: 20435447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and cross-cultural adaption of an instrument measuring patient's well-being under treatment for schizophrenia.
    Julaeha J; Athiyah U; Maramis MM; Sugianto A; Hermansyah A
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):341-347. PubMed ID: 34214321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20).
    Siamouli M; Moutou K; Pantoula E; Magiria S; Chatzivasileiou I; Arapidis K; Chatzivasileiou A; Deres S; Fountoulakis KN
    Ann Gen Psychiatry; 2009 Jan; 8():3. PubMed ID: 19159480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study.
    Teetharatkul T; Vitayanont A; Liabsuetrakul T; Aunjitsakul W
    BMC Psychiatry; 2021 Jul; 21(1):348. PubMed ID: 34253169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls.
    Vothknecht S; Meijer C; Zwinderman A; Kikkert M; Dekker J; van Beveren N; Schoevers R; de Haan L;
    Psychiatry Res; 2013 Mar; 206(1):62-7. PubMed ID: 23021423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.
    Karow A; Czekalla J; Dittmann RW; Schacht A; Wagner T; Lambert M; Schimmelmann BG; Naber D
    J Clin Psychiatry; 2007 Jan; 68(1):75-80. PubMed ID: 17284133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
    Naber D
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():133-8. PubMed ID: 8866775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Psychiatrist's Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient's Well-Being Perception than Clinical Judgement Alone?
    Aunjitsakul W; Teetharatkul T; Vitayanont A; Liabsuetrakul T
    Adm Policy Ment Health; 2021 Sep; 48(5):768-779. PubMed ID: 33728557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].
    Reine G; Bernard D; Auquier P; Le Fur B; Lançon C
    Encephale; 2000; 26(1):52-61. PubMed ID: 10875062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
    Majadas S; Olivares J; Galan J; Diez T
    Compr Psychiatry; 2012 Feb; 53(2):145-51. PubMed ID: 21621754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial.
    Chen L; Phillips G; Johnston J; Kinon BJ; Ascher-Svanum H; Kollack-Walker S; Succop P; Naber D
    BMC Psychiatry; 2011 Dec; 11():203. PubMed ID: 22204569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.